In ovarian cancer, miR-183 regulates cell proliferation and apoptosis by targeting Smad4 (Recombinant Mothers Against Decapentaplegic Homolog 4) through the TGF-β/Smad4 signaling pathway [15]. This evidence concerns the gene SMAD4 and ovarian carcinoma.